Antithrombotic

Product descriptionSoft capsules Vessel Due F are indicated for:angiopathy with an increased risk of thrombus formation, including after myocardial infarction;disorders of cerebral circulation, including the acute period of ischemic stroke and the period of early recovery; discirculatory encephalopa..

Product descriptionXarelto tablets are indicated for:Prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation and one or more risk factors, such as congestive heart failure, arterial hypertension, age ≥ 75 years, diabetes mellitus, stroke, or a history of tra..

Product descriptionXarelto® tablets are used for the following indications:prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation and one or more risk factors, such as congestive heart failure, arterial hypertension, age ≥ 75 years, diabetes mellitus, stro..

Product descriptionWarfarex tablets are indicated for:prevention and treatment of deep vein thrombosis and pulmonary embolism;secondary prevention of myocardial infarction and prevention of thromboembolic complications (stroke or systemic embolism) after myocardial infarction;prevention of thromboem..

Pharmacological propertiesTiclopidine ([5- (2- [chlorophenyl) -4,5,6,7, -tetrahydrothieno [3,2-c] pyridine hydrochloride) is an antiplatelet agent with a peculiar pharmacological profile (mechanism of action). ticlopidine exhibits an antagonistic effect against ADP, inhibits platelet aggregation and..

Product descriptionXarelto tablets are indicated for:Prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation and one or more risk factors, such as congestive heart failure, arterial hypertension, age ≥ 75 years, diabetes mellitus, stroke, or a history of tra..

Product descriptionXarelto is prescribed in combination with acetylsalicylic acid (ASA) or in combination with ASA and clopidogrel or ticlopidine to prevent atherothrombotic events in adult patients after acute coronary syndrome (ACS) with an increased level of cardiac biomarkers.Xarelto is prescrib..

Product descriptionXarelto tablets are used for the following indications:Prevention of venous thromboembolism (VTE) in adult patients undergoing surgery for hip or knee arthroplasty.Treatment of deep vein thrombosis (DVT), pulmonary embolism (PE) and prevention of recurrence of DVT and PE in adults..

Product descriptionXarelto® tablets are used for the following indications:prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation and one or more risk factors, such as congestive heart failure, arterial hypertension, age ≥ 75 years, diabetes mellitus, stro..

Product descriptionWarfarex tablets are indicated for:prevention and treatment of deep vein thrombosis and pulmonary embolism;secondary prevention of myocardial infarction and prevention of thromboembolic complications (stroke or systemic embolism) after myocardial infarction;prevention of thromboem..

Product descriptionXarelto tablets are used for the following indications:Prevention of venous thromboembolism (VTE) in adult patients undergoing surgery for hip or knee arthroplasty.Treatment of deep vein thrombosis (DVT), pulmonary embolism (PE) and prevention of recurrence of DVT and PE in adults..